
Popular equity categories lag in FY25; pharma schemes returned much more than the rest
Pharma sector funds emerged as the top performing category among mutual funds in the financial year ended March 31, 2025, outperforming plain vanilla equity schemes. The risk-off sentiment in the second half of the financial year eroded a chunk of the …